Lucid Diagnostics Inc (LUCD) Prices 13.94M Share Offering at $1.10/sh
Get Alerts LUCD Hot Sheet
Join SI Premium – FREE
Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that it has entered into subscription agreements with certain accredited investors to sell 13,939,331 shares of common stock at a purchase price of
Canaccord Genuity is acting as the sole placement agent for this offering.
The closing of the offering is expected to occur on or about
The securities described above are being offered pursuant to a registration statement on Form S-3 (File No. 333-268560), which was declared effective by the Securities and Exchange Commission on
This press release shall not constitute an offer to sell or a solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Evolution Petroleum prices stock offering at $3.25 per share
- K Wave Media prices $1M registered direct offering at $1.90 per share
- Alliance Laundry principal stockholder prices 22.55M share offering
Create E-mail Alert Related Categories
Corporate News, Equity OfferingsRelated Entities
S3, Canaccord Genuity, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share